In the global medical devices industry, there were 130 M&A deals announced in Q4 2023, worth a total value of $9.4bn, according to GlobalData’s Deals Database. The $3.1bn acquisition of Olink Holding by Orion Acquisition was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.

Smarter leaders trust GlobalData

In value terms, M&A activity increased by 124% in Q4 2023 compared with the previous quarter’s total of $4.2bn and fell by 73% as compared to Q4 2022. Related deal volume increased by 18% in Q4 2023 versus the previous quarter and was 10% lower than in Q4 2022.

Notably, foreign direct investments (fdi)-related deals accounted for a 32% share of the global medical devices industry’s M&A activity in Q4 2023, up 2% over the previous quarter.

The top-ranked financial advisors supporting these M&A deals in Q4 2023 were Piper Sandler Companies; Goldman Sachs Group; Lazard with 13, 5, 5 deals respectively.

The top-ranked legal advisors supporting these M&A deals in Q4 2023 were CMS Legal Services EEIG; Baker & McKenzie; Morgan, Lewis & Bockius with 10, 8, 7 deals respectively.

For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In 2023 – Thematic Intelligence, buy the report here.

This content was updated on 8 January 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.